ATE477007T1 - Bioaktive biomaterialien zur kontrollierten wirkstofffreisetzung - Google Patents

Bioaktive biomaterialien zur kontrollierten wirkstofffreisetzung

Info

Publication number
ATE477007T1
ATE477007T1 AT05778669T AT05778669T ATE477007T1 AT E477007 T1 ATE477007 T1 AT E477007T1 AT 05778669 T AT05778669 T AT 05778669T AT 05778669 T AT05778669 T AT 05778669T AT E477007 T1 ATE477007 T1 AT E477007T1
Authority
AT
Austria
Prior art keywords
biomaterials
covalently linked
active ingredients
controlled release
substituted
Prior art date
Application number
AT05778669T
Other languages
English (en)
Inventor
Marie-Christine Durrieu
Damien Quemener
Charles Baquey
Valerie Sabaut-Heroguez
Original Assignee
Centre Nat Rech Scient
Inst Nat Sante Rech Med
Univ Bordeaux 1
Ecole Nale Sup Artes Metiers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Inst Nat Sante Rech Med, Univ Bordeaux 1, Ecole Nale Sup Artes Metiers filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE477007T1 publication Critical patent/ATE477007T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05778669T 2004-06-21 2005-06-21 Bioaktive biomaterialien zur kontrollierten wirkstofffreisetzung ATE477007T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0406708A FR2871701B1 (fr) 2004-06-21 2004-06-21 Biomateriaux bioactifs pour le relarguage controle de principes actifs
PCT/FR2005/001545 WO2006008386A1 (fr) 2004-06-21 2005-06-21 Biomateriaux bioactifs pour le relargage controle de principes actifs

Publications (1)

Publication Number Publication Date
ATE477007T1 true ATE477007T1 (de) 2010-08-15

Family

ID=34946356

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05778669T ATE477007T1 (de) 2004-06-21 2005-06-21 Bioaktive biomaterialien zur kontrollierten wirkstofffreisetzung

Country Status (8)

Country Link
US (1) US20080004398A1 (de)
EP (1) EP1758621B1 (de)
JP (1) JP5383039B2 (de)
AT (1) ATE477007T1 (de)
DE (1) DE602005022862D1 (de)
ES (1) ES2350527T3 (de)
FR (1) FR2871701B1 (de)
WO (1) WO2006008386A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9408607B2 (en) * 2009-07-02 2016-08-09 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US9585743B2 (en) 2006-07-31 2017-03-07 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
EP3360509B1 (de) 2006-07-31 2022-06-22 Syntheon TAVR, LLC Verschliessbare endovaskuläre implantate
US9814611B2 (en) 2007-07-31 2017-11-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9566178B2 (en) 2010-06-24 2017-02-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
WO2010033726A2 (en) 2008-09-17 2010-03-25 The Brigham And Women's Hospital, Inc. Drug delivery composition comprising a self-assembled gelator
RU2397975C1 (ru) * 2008-11-27 2010-08-27 Андрей Александрович Иващенко Замещенные 2-(5-гидрокси-2-метил-1н-индол-3-ил)уксусные кислоты и их эфиры, противовирусное активное начало, фармацевтическая композиция, лекарственное средство, способ лечения вирусных заболеваний
BR112013008697A2 (pt) 2010-09-24 2016-06-21 Massachusetts Inst Technology géis nanoestruturados capazes de liberação controlada de agentes encapsulados
US9644042B2 (en) 2010-12-17 2017-05-09 Carnegie Mellon University Electrochemically mediated atom transfer radical polymerization
US20140275420A1 (en) * 2011-08-22 2014-09-18 Carnegie Mellon University Atom transfer radical polymerization under biologically compatible conditions
US9827093B2 (en) 2011-10-21 2017-11-28 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
EP3237488A1 (de) * 2014-12-18 2017-11-01 Université de Bordeaux Polymerteilchen und biomaterialien damit
EP3034538A1 (de) * 2014-12-18 2016-06-22 Universite De Bordeaux Polymerteilchen und Biomaterialien damit
US9982070B2 (en) 2015-01-12 2018-05-29 Carnegie Mellon University Aqueous ATRP in the presence of an activator regenerator
US9962339B2 (en) 2015-10-08 2018-05-08 The Brigham And Women's Hospital, Inc. Stabilized assembled nanostructures for delivery of encapsulated agents
EP3452094B1 (de) 2016-05-06 2021-11-17 The Brigham and Women's Hospital, Inc. Binäre selbstangeordnete gele zur kontrollierten abgabe von verkapselten wirkstoffen an knorpel
WO2018132582A1 (en) 2017-01-12 2018-07-19 Carnegie Mellon University Surfactant assisted formation of a catalyst complex for emulsion atom transfer radical polymerization processes
US11020410B2 (en) 2017-02-03 2021-06-01 The Brigham And Women's Hospital, Inc. Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof
US10881745B2 (en) 2017-05-08 2021-01-05 Alivio Therapeutics, Inc. Formulation of nanostructured gels for increased agent loading and adhesion
CA3113948A1 (en) 2018-10-11 2020-04-16 Alivio Therapeutics, Inc. Non-injectable hydrogel formulations for smart release

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791189A (en) * 1987-05-07 1988-12-13 The B. F. Goodrich Company Terminally unsaturated macromolecular monomers of polylactones and copolymers thereof
US5356433A (en) * 1991-08-13 1994-10-18 Cordis Corporation Biocompatible metal surfaces
US5607475A (en) * 1995-08-22 1997-03-04 Medtronic, Inc. Biocompatible medical article and method
EP1135682B1 (de) * 1998-11-30 2007-07-11 Nanosphere, Inc. Nanopartikel mit polymerschalen
US8158106B2 (en) * 2001-10-05 2012-04-17 Surmodics, Inc. Particle immobilized coatings and uses thereof
EP1371699A3 (de) * 2002-06-14 2004-01-14 Rohm And Haas Company Polymere Nanopartikel und antimikrobielle Beschichtungsformulierungen

Also Published As

Publication number Publication date
ES2350527T3 (es) 2011-01-24
EP1758621A1 (de) 2007-03-07
JP5383039B2 (ja) 2014-01-08
FR2871701A1 (fr) 2005-12-23
FR2871701B1 (fr) 2006-09-22
JP2008503553A (ja) 2008-02-07
US20080004398A1 (en) 2008-01-03
DE602005022862D1 (de) 2010-09-23
WO2006008386A1 (fr) 2006-01-26
EP1758621B1 (de) 2010-08-11

Similar Documents

Publication Publication Date Title
ATE477007T1 (de) Bioaktive biomaterialien zur kontrollierten wirkstofffreisetzung
Guo et al. Recent progress in synthesis and application of mussel-inspired adhesives
Li et al. Mineral-enhanced polyacrylic acid hydrogel as an oyster-inspired organic–inorganic hybrid adhesive
Kord Forooshani et al. Recent approaches in designing bioadhesive materials inspired by mussel adhesive protein
Ghanbari et al. In vitro study of alginate–gelatin scaffolds incorporated with silica NPs as injectable, biodegradable hydrogels
Carr et al. Functionalizable and nonfouling zwitterionic carboxybetaine hydrogels with a carboxybetaine dimethacrylate crosslinker
Radvar et al. Supramolecular peptide/polymer hybrid hydrogels for biomedical applications
Zhan et al. Tunicate-inspired gallol polymers for underwater adhesive: a comparative study of catechol and gallol
Sagnella et al. Chitosan based surfactant polymers designed to improve blood compatibility on biomaterials
Pan et al. Thermo-responsive hydrogel layers imprinted with RGDS peptide: a system for harvesting cell sheets.
Perlin et al. Production and performance of biomaterials containing RGD peptides
Lee et al. Phase controllable hyaluronic acid hydrogel with iron (III) ion–catechol induced dual cross-linking by utilizing the gap of gelation kinetics
Teng et al. Weak hydrogen bonds lead to self-healable and bioadhesive hybrid polymeric hydrogels with mineralization-active functions
Saxer et al. Surface assembly of catechol-functionalized poly (l-lysine)-graft-poly (ethylene glycol) copolymer on titanium exploiting combined electrostatically driven self-organization and biomimetic strong adhesion
Dong et al. A rapid crosslinking injectable hydrogel for stem cell delivery, from multifunctional hyperbranched polymers via RAFT homopolymerization of PEGDA
Overstreet et al. In situ forming, resorbable graft copolymer hydrogels providing controlled drug release
Mauro et al. RGD‐mimic polyamidoamine–montmorillonite composites with tunable stiffness as scaffolds for bone tissue‐engineering applications
Xu et al. Arginine-based polymer brush coatings with hydrolysis-triggered switchable functionalities from antimicrobial (Cationic) to antifouling (Zwitterionic)
Peng et al. Scarless wound closure by a mussel-inspired poly (amidoamine) tissue adhesive with tunable degradability
Tian et al. Single-chain nanoparticle-based coatings with improved bactericidal activity and antifouling properties
Yao et al. Porous chitosan scaffold cross-linked by chemical and natural procedure applied to investigate cell regeneration
Bubenikova et al. Chemoselective cross-linking of alginate with thiol-terminated peptides for tissue engineering applications
Hong et al. Controlling mechanical properties of bio-inspired hydrogels by modulating nano-scale, inter-polymeric junctions
Das et al. Effects of molar ratios of two immiscible monomers toward development of an amphiphilic, highly stretchable, bioadhesive, self-healing copolymeric hydrogel and its mineral-active cellular behavior
He et al. Preparation of a bio-composite of sericin-g-PMMA via HRP-mediated graft copolymerization

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties